(AS) Amer Sports - Overview
Stock: Apparel, Footwear, Equipment, Accessories, Skis
| Risk 5d forecast | |
|---|---|
| Volatility | 52.4% |
| Relative Tail Risk | -6.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | -7.02 |
| Character TTM | |
|---|---|
| Beta | 1.456 |
| Beta Downside | 1.009 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.71% |
| CAGR/Max DD | 1.39 |
EPS (Earnings per Share)
Revenue
Description: AS Amer Sports February 28, 2026
Amer Sports, Inc. (NYSE: AS) is a Helsinki-based global designer, manufacturer and marketer of sports equipment, apparel, footwear and accessories, operating across Europe, the Middle East, Africa, the Americas and the Asia-Pacific. The business is organized into three segments: Technical Apparel (outdoor apparel, climbing gear and footwear), Outdoor Performance (hiking, running, ski and lifestyle footwear) and Ball & Racquet Sports (tennis, baseball, football, basketball, golf equipment and custom-fit protective gear). Its portfolio includes well-known brands such as Arc’teryx, Salomon, Atomic, Wilson and Louisville Slugger.
In FY 2025 Amer reported net sales of €5.2 billion, a 7 % year-over-year increase driven by strong demand for premium outdoor apparel and a rebound in North American ball-sport equipment sales. Adjusted EBITDA margin expanded to 12.5 % from 10.8 % in FY 2024, reflecting higher pricing power and improved supply-chain efficiency. The company’s e-commerce share grew to 18 % of total revenue, outpacing the broader sports-goods sector’s average of 12 %.
Key macro drivers for Amer include rising discretionary consumer spending in mature markets, continued growth in outdoor recreation participation (projected CAGR 4.2 % through 2028), and a shift toward “experience-driven” sports that favors premium, technically advanced gear. Currency headwinds remain a risk, as a stronger euro could compress margins on sales outside the Eurozone.
For a deeper dive into Amer Sports’ valuation metrics and how they compare to peers, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 427.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.50 > 1.0 |
| NWC/Revenue: 16.67% < 20% (prev 16.30%; Δ 0.37% < -1%) |
| CFO/TA 0.05 > 3% & CFO 511.2m > Net Income 427.4m |
| Net Debt (1.76b) to EBITDA (828.5m): 2.13 < 3 |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (563.7m) vs 12m ago 7.46% < -2% |
| Gross Margin: 57.63% > 18% (prev 0.55%; Δ 5708 % > 0.5%) |
| Asset Turnover: 71.37% > 50% (prev 62.18%; Δ 9.19% > 0%) |
| Interest Coverage Ratio: 7.39 > 6 (EBITDA TTM 828.5m / Interest Expense TTM 97.7m) |
Altman Z'' 1.81
| A: 0.11 (Total Current Assets 3.30b - Total Current Liabilities 2.21b) / Total Assets 10.06b |
| B: -0.02 (Retained Earnings -213.6m / Total Assets 10.06b) |
| C: 0.08 (EBIT TTM 722.2m / Avg Total Assets 9.20b) |
| D: 0.61 (Book Value of Equity 2.59b / Total Liabilities 4.24b) |
| Altman-Z'' Score: 1.81 = BBB |
Beneish M -3.04
| DSRI: 0.88 (Receivables 829.6m/746.7m, Revenue 6.57b/5.18b) |
| GMI: 0.96 (GM 57.63% / 55.41%) |
| AQI: 0.90 (AQ_t 0.53 / AQ_t-1 0.58) |
| SGI: 1.27 (Revenue 6.57b / 5.18b) |
| TATA: -0.01 (NI 427.4m - CFO 511.2m) / TA 10.06b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of AS shares?
Over the past week, the price has changed by -10.53%, over one month by -9.41%, over three months by -8.63% and over the past year by +20.11%.
Is AS a buy, sell or hold?
- StrongBuy: 11
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.8 | 43.5% |
| Analysts Target Price | 48.8 | 43.5% |
AS Fundamental Data Overview March 03, 2026
P/E Forward = 34.2466
P/S = 3.2077
P/B = 3.7301
P/EG = 1.1354
Revenue TTM = 6.57b USD
EBIT TTM = 722.2m USD
EBITDA TTM = 828.5m USD
Long Term Debt = 791.9m USD (from longTermDebt, two quarters ago)
Short Term Debt = 299.9m USD (from shortTermDebt, last quarter)
Debt = 2.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.76b USD (from netDebt column, last quarter)
Enterprise Value = 22.82b USD (21.06b + Debt 2.41b - CCE 652.3m)
Interest Coverage Ratio = 7.39 (Ebit TTM 722.2m / Interest Expense TTM 97.7m)
EV/FCF = 84.63x (Enterprise Value 22.82b / FCF TTM 269.7m)
FCF Yield = 1.18% (FCF TTM 269.7m / Enterprise Value 22.82b)
FCF Margin = 4.11% (FCF TTM 269.7m / Revenue TTM 6.57b)
Net Margin = 6.51% (Net Income TTM 427.4m / Revenue TTM 6.57b)
Gross Margin = 57.63% ((Revenue TTM 6.57b - Cost of Revenue TTM 2.78b) / Revenue TTM)
Gross Margin QoQ = 57.69% (prev 56.84%)
Tobins Q-Ratio = 2.27 (Enterprise Value 22.82b / Total Assets 10.06b)
Interest Expense / Debt = 0.83% (Interest Expense 20.1m / Debt 2.41b)
Taxrate = 35.63% (73.9m / 207.4m)
NOPAT = 464.9m (EBIT 722.2m * (1 - 35.63%))
Current Ratio = 1.50 (Total Current Assets 3.30b / Total Current Liabilities 2.21b)
Debt / Equity = 0.42 (Debt 2.41b / totalStockholderEquity, last quarter 5.80b)
Debt / EBITDA = 2.13 (Net Debt 1.76b / EBITDA 828.5m)
Debt / FCF = 6.53 (Net Debt 1.76b / FCF TTM 269.7m)
Total Stockholder Equity = 5.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.65% (Net Income 427.4m / Total Assets 10.06b)
RoE = 7.71% (Net Income TTM 427.4m / Total Stockholder Equity 5.54b)
RoCE = 11.40% (EBIT 722.2m / Capital Employed (Equity 5.54b + L.T.Debt 791.9m))
RoIC = 7.20% (NOPAT 464.9m / Invested Capital 6.46b)
WACC = 10.18% (E(21.06b)/V(23.48b) * Re(11.28%) + D(2.41b)/V(23.48b) * Rd(0.83%) * (1-Tc(0.36)))
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.31%
[DCF] Terminal Value 74.53% ; FCFF base≈201.3m ; Y1≈248.3m ; Y5≈422.9m
[DCF] Fair Price = 5.74 (EV 4.94b - Net Debt 1.76b = Equity 3.18b / Shares 554.6m; r=10.18% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 78.98 | EPS CAGR: 456.8% | SUE: 0.46 | # QB: 0
Revenue Correlation: 81.08 | Revenue CAGR: 32.23% | SUE: N/A | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.07 | Chg7d=-0.004 | Chg30d=-0.002 | Revisions Net=+1 | Analysts=13
EPS current Year (2026-12-31): EPS=1.18 | Chg7d=+0.009 | Chg30d=+0.016 | Revisions Net=+4 | Growth EPS=+21.9% | Growth Revenue=+17.5%
EPS next Year (2027-12-31): EPS=1.50 | Chg7d=+0.004 | Chg30d=+0.014 | Revisions Net=+4 | Growth EPS=+26.7% | Growth Revenue=+14.3%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.8% (Discount Rate 11.3% - Earnings Yield 1.4%)
[Growth] Growth Spread = +10.4% (Analyst 20.2% - Implied 9.8%)